Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1320, 2002-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Risperidone a better bet for schizophrenia
Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. :
Olanzapine and risperidone on a par in schizophrenia
Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. :
Risperidone a better bet for schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 285, 2000-01 ,pp. :
Olanzapine and risperidone on a par in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. :
Escitalopram worth it for preventing SAD relapse
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 421, 2003-01 ,pp. :